Skip to content
ANNOUCEMENT:  Teleflex has entered into a definitive agreement to divest our Interventional Urology portfolio, including the UroLift System™, Barrigel™ rectal spacer, Deflux™ injectable gel, and Solesta™ bulking agent, to Intersurgical®. This transaction is expected to close in the second half of 2026, subject to customary regulatory approvals and other closing conditions.
 
We’re excited about this opportunity and remain committed to providing the same high-quality products, reliable service, and on-time delivery our customers expect. We will keep our physicians and patients informed throughout the transition. Please feel free to contact your sales representative with any questions or concerns.
Doctor looking at a laptop screen

For Physicians

UroLift icon

The UroLift System

An early alternative to medical therapy that provides rapid relief and recovery of BPH symptoms.1,3,4 The UroLift™ System is minimally invasive and offers better symptom relief than medication4 with a lower risk profile than TURP.2

Learn More About the Procedure
Icon of a line graph

Results

The UroLift System is supported by extensive clinical experience in controlled studies; large multi-centre studies; small studies; retrospective registry and peer-reviewed publications.

Explore the Results
Icon of a book

Publications

View the spectrum of UroLift System clinical results and data:

  • Meta-Analyses
  • Real World Experience Studies
  • Clinical Studies
  • International Publications
  • Reviews
View More Publications
IFU document icon

Instructions for Use

Download the UroLift System Instructions for Use document to learn more about:

  • Product Description
  • Device Positioning (Lateral and Median Lobes)
  • Implant Deployment
  • MRI Safety Information
See Instructions for Use

Source Information

  • 1. Shore, Can J Urol 2014

  • 2. Sonksen, Eur Urol 2015

  • 3. Roehrborn, J Urology 2013

  • 4. Roehrborn, Can J Urol, 2017